US Broker Ratings

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring a 23.50% Upside Potential in Biotech Innovation

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its innovative approach to drug delivery systems. Headquartered in San Diego, California, this..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 118% Potential Upside in Oncology Biotech

Legend Biotech Corporation (NASDAQ: LEGN) is capturing investor attention with its impressive growth trajectory in the biotechnology sector, particularly in developing innovative cell therapies for oncology...

Fresenius Medical Care AG (FMS): Investor Outlook on a German Healthcare Giant with a Stable Dividend Yield

Fresenius Medical Care AG (FMS) stands as a formidable player in the healthcare sector, particularly within the medical care facilities industry. Based in Germany, this multinational..

Viatris Inc. (VTRS) Stock Analysis: Navigating Opportunities Amidst A Potential 30% Upside

Investors are taking a closer look at Viatris Inc. (VTRS), a prominent player in the healthcare sector with a specialization in both specialty and generic drug..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A 32.6% Upside Potential Beckons Investors

Teva Pharmaceutical Industries (TEVA), a stalwart in the healthcare sector, continues to hold a significant position in the global pharmaceutical industry, specializing in drug manufacturing—particularly in..

ResMed Inc. (RMD) Investor Outlook: Evaluating a 4.87% Potential Upside in Healthcare Innovations

ResMed Inc. (RMD), a prominent player in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with its innovative approach to respiratory..

Solventum Corporation (SOLV): Healthcare Innovator with a 9.79% Potential Upside

Solventum Corporation (SOLV), a prominent player in the healthcare sector, stands out with a market capitalization of $12.95 billion. As a company entrenched in the Medical..

Roivant Sciences Ltd. (ROIV): Investor Outlook with a Promising 49% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline and significant potential upside. Based in..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 22% Upside Potential Awaits Investors

GE HealthCare Technologies Inc. (NYSE: GEHC), a leading player in the healthcare sector, has garnered significant interest from investors, thanks to its robust growth potential and..

DaVita Inc. (DVA) Stock Analysis: Investor Outlook Highlights 18% Potential Upside

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is catching the attention of investors with its..

Humana Inc. (HUM) Stock Analysis: Navigating a 30% Potential Upside Amidst Healthcare Sector Dynamics

Humana Inc. (NYSE: HUM), a heavyweight in the healthcare plans industry, stands as a compelling consideration for investors eyeing growth within the healthcare sector. With a..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 73% Potential Upside Amidst Challenging Metrics

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative mRNA-based therapeutic solutions. Despite facing a..

West Pharmaceutical Services (WST) Stock Analysis: Healthcare Giant with 25% Upside Potential

West Pharmaceutical Services, Inc. (WST), a key player in the healthcare sector, is capturing the attention of investors with a compelling growth potential. With a market..

Centene Corporation (CNC) Stock Analysis: Unlocking a Potential 39% Upside Amidst Market Challenges

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, stands out with a market capitalization of $27.45 billion. Operating primarily in the healthcare plans..

Boston Scientific Corporation (BSX) Stock Analysis: A 14.63% Upside Potential Amid Robust Revenue Growth

Boston Scientific Corporation (NYSE: BSX), a leading player in the medical devices sector, offers a compelling investment proposition with a notable 14.63% potential upside, as indicated..

Grifols, S.A. (GRFS) Stock Analysis: Unlocking a 22.85% Potential Upside with Its Global Plasma Leadership

Grifols, S.A. (GRFS), a leading player in the healthcare sector, particularly within the general drug manufacturing industry, is drawing attention from investors with its significant potential..

Elanco Animal Health (ELAN) Stock Analysis: Navigating the Path with Strong Free Cash Flow and Growth Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, offers a diverse portfolio..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring Growth Potential with a 4.24% Upside

Cardinal Health, Inc. (CAH), a prominent player in the healthcare sector, operates within the medical distribution industry, delivering essential services and products across the globe. With..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Analyzing the 83.45% Potential Upside in Biotech

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a noteworthy contender in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $15.29 billion,..

Verona Pharma (VRNA) Stock Analysis: Exploring a Significant 12% Upside Potential in the Biotech Sector

Verona Pharma plc (NASDAQ: VRNA), a key player in the biotechnology industry, has captured investor attention with its promising prospects in the healthcare sector. Operating out..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds